Certified by Founder
Lodge
GFO-X
start up
United Kingdom
- London, England
- 12/12/2023
- Series B
- $30,000,000
The UK's first regulated and centrally cleared trading venue dedicated to digital asset derivatives authorised and regulated by the UK Financial Conduct Authority. Firm reference number 945035.
- Industry Financial Services
- Website https://www.gfo-x.com/
- LinkedIn https://www.linkedin.com/company/gfo-x/about/
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)